Dr. Paul Trombley, MD

NPI: 1164593604
Total Payments
$8,443
2024 Payments
$1,264
Companies
28
Transactions
558
Medicare Patients
452
Medicare Billing
$129,514

Payment Breakdown by Category

Food & Beverage$8,327 (98.6%)
Education$116.23 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,327 554 98.6%
Education $116.23 4 1.4%

Top Paying Companies

Company Total Records Latest Year
Lundbeck LLC $1,246 104 $0 (2024)
ABBVIE INC. $1,083 76 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $933.45 92 $0 (2024)
Supernus Pharmaceuticals, Inc. $923.63 36 $0 (2024)
Neos Therapeutics, LP $764.71 49 $0 (2024)
Otsuka America Pharmaceutical, Inc. $559.91 22 $0 (2024)
Allergan, Inc. $459.77 51 $0 (2020)
ITI, Inc. $451.57 16 $0 (2023)
Corium, LLC $433.46 23 $0 (2024)
Axsome Therapeutics, Inc. $282.76 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,264 54 Supernus Pharmaceuticals, Inc. ($318.77)
2023 $1,427 81 AbbVie Inc. ($444.39)
2022 $1,175 69 Supernus Pharmaceuticals, Inc. ($219.27)
2021 $1,482 91 Takeda Pharmaceuticals U.S.A., Inc. ($308.72)
2020 $808.52 71 Lundbeck LLC ($230.96)
2019 $971.19 93 Lundbeck LLC ($352.78)
2018 $1,117 83 Neos Therapeutics, LP ($324.73)
2017 $199.14 16 Takeda Pharmaceuticals America, Inc. ($87.72)

All Payment Transactions

558 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
11/26/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.03 General
Category: NEUROSCIENCE
11/21/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.07 General
Category: NEUROSCIENCE
11/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $21.85 General
Category: VILOXAZINE HYDROCHLORIDE
10/10/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $24.76 General
Category: VILOXAZINE HYDROCHLORIDE
09/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.95 General
Category: NEUROSCIENCE
09/17/2024 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $13.25 General
Category: ADHD
09/13/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $35.91 General
Category: SCHIZOPHRENIA
08/21/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $19.58 General
Category: VILOXAZINE HYDROCHLORIDE
08/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.34 General
Category: NEUROSCIENCE
07/24/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $20.40 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
07/16/2024 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage Cash or cash equivalent $14.71 General
Category: ADHD
07/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.48 General
Category: NEUROSCIENCE
07/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $23.04 General
Category: VILOXAZINE HYDROCHLORIDE
06/06/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $24.32 General
Category: VILOXAZINE HYDROCHLORIDE
06/04/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $28.47 General
Category: Psychology/Psychiatric
05/31/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.27 General
Category: PSYCHIATRY
05/22/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $28.98 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
05/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.50 General
Category: NEUROSCIENCE
05/08/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $31.32 General
Category: PSYCHIATRY
05/08/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.94 General
Category: NEUROSCIENCE
05/04/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $23.07 General
Category: VILOXAZINE HYDROCHLORIDE
04/30/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $23.81 General
Category: PSYCHIATRY
04/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $26.32 General
Category: PSYCHIATRY
04/17/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $34.84 General
Category: CNS Stimulant for ADHD
04/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.40 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 89 258 $29,415 $19,608
2022 2 92 354 $43,170 $27,659
2021 3 122 516 $62,025 $38,551
2020 4 149 642 $85,375 $43,695
Total Patients
452
Total Services
1,770
Medicare Billing
$129,514
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 61 195 $24,375 $16,166 66.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 28 63 $5,040 $3,442 68.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 74 330 $41,250 $26,266 63.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 18 24 $1,920 $1,394 72.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 88 461 $57,625 $35,663 61.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 18 33 $2,640 $1,746 66.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 16 22 $1,760 $1,143 64.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 102 595 $74,375 $39,529 53.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 23 23 $7,820 $2,183 27.9%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 12 12 $2,220 $1,498 67.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 12 12 $960.00 $486.00 50.6%

About Dr. Paul Trombley, MD

Dr. Paul Trombley, MD is a Psychiatry healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164593604.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Trombley, MD has received a total of $8,443 in payments from pharmaceutical and medical device companies, with $1,264 received in 2024. These payments were reported across 558 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($8,327).

As a Medicare-enrolled provider, Trombley has provided services to 452 Medicare beneficiaries, totaling 1,770 services with total Medicare billing of $129,514. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Pediatrics, Child & Adolescent Psychiatry
  • Location Charlotte, NC
  • Active Since 11/13/2006
  • Last Updated 02/15/2016
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1164593604

Products in Payments

  • VRAYLAR (Drug) $1,542
  • REXULTI (Drug) $925.70
  • BRINTELLIX (Drug) $775.91
  • QELBREE (Drug) $604.86
  • Adzenys XR-ODT (Drug) $536.25
  • TRINTELLIX (Drug) $521.53
  • CAPLYTA (Drug) $487.78
  • Qelbree (Drug) $318.77
  • Trintellix (Drug) $313.49
  • Azstarys (Drug) $307.74
  • Auvelity (Drug) $282.76
  • Cotempla XR-ODT (Drug) $196.08
  • JORNAY PM (Drug) $172.31
  • VYVANSE (Drug) $163.04
  • LATUDA (Drug) $152.06
  • Quillivant (Drug) $136.31
  • AZSTARYS (Drug) $125.72
  • SPRAVATO (Drug) $114.89
  • Entyvio (Biological) $94.56
  • Dayvigo (Drug) $85.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Charlotte